LINC02964: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC02964

NCBI ID: G105375746

Other Name(s): long intergenic non-protein coding RNA 2964 | Long intergenic non-protein coding RNA 2964, transcript variant X1 | LINC02964 variant X1

LINC02964: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

LINC02964 is a long non-coding RNA (lncRNA) that has been identified in various studies as having potential drug targets or biomarkers. It is a transcribed RNA molecule that is longer than 200 nucleotides and is not translated into a protein. In recent years, the study of lncRNAs has gained significant interest due to their potential involvement in various biological processes. LINC02964 is one of these lncRNAs that has caught researchers' attention due to its unique properties and potential implications as a drug target or biomarker.

Drug Target Potential

LINC02964 has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation. Several studies have demonstrated that LINC02964 can interact with various protein molecules and play a role in modulating their activity. For instance, LINC02964 has been shown to interact with the protein SMAD4, which is a transcription factor that is involved in regulating various cellular processes, including cell growth, apoptosis, and inflammation.

Several studies have also shown that LINC02964 can be regulated by various signaling pathways, including NF-kappa signaling pathway. This pathway is involved in regulating cell growth, differentiation, and inflammation, and has been implicated in various diseases, including cancer. LINC02964 has been shown to be regulated by NF-kappa signaling through its interaction with the protein FGF17, which is a critical signaling molecule in this pathway.

Biomarker Potential

LINC02964 has also been shown to be involved in the regulation of various biological processes, including cell signaling, inflammation, and metabolism. Several studies have demonstrated that LINC02964 can be regulated by various signaling pathways, including NF-kappa, NF-kappa-B, and PI3K/AKT signaling pathways. These signaling pathways are involved in regulating various cellular processes, including cell growth, differentiation, inflammation, and metabolism.

LINC02964 has also been shown to be regulated by various gene expression networks, including the RNA regulatory network (RRN) and the microRNA (miRNA) network. The RRN is a complex of RNA-protein interactions that regulates gene expression, while the miRNA network is a set of small non-coding RNAs that act as negative regulators of gene expression. LINC02964 has been shown to interact with various miRNAs, including miR-18a, miR-30a, and miR-1286, which are involved in regulating various cellular processes, including cell growth, apoptosis, and inflammation.

Conclusion

In conclusion, LINC02964 is a long non-coding RNA that has been identified in various studies as having potential drug targets or biomarkers. Its unique properties and involvement in various cellular processes make it an attractive candidate for further study. Further research is needed to fully understand the role of LINC02964 in various biological processes and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2964

More Common Targets